For the quarter ending 2025-09-30, BCRX made $159,395,000 in revenue. $12,393,000 in net income. Net profit margin of 7.78%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenues | 159,395,000 | 163,353,000 | 145,534,000 | 112,147,500 |
| Cost of product sales | 2,187,000 | 2,798,000 | 4,568,000 | 3,679,500 |
| Research and development | 44,603,000 | 43,386,000 | 37,270,000 | 47,967,000 |
| Selling, general and administrative | 83,014,000 | 87,383,000 | 82,469,000 | 69,917,000 |
| Total operating expenses | 129,804,000 | 133,567,000 | 124,307,000 | 121,645,500 |
| Income from operations | 29,591,000 | 29,786,000 | 21,227,000 | -9,498,000 |
| Interest income | 2,238,000 | 2,516,000 | 3,024,000 | 3,800,500 |
| Interest expense | 19,661,000 | 21,582,000 | 23,494,000 | 24,562,666.667 |
| Foreign currency gains (losses), net | 35,000 | -63,000 | 1,000 | -327,500 |
| Loss on extinguishment of debt | -2,740,000 | -4,171,000 | - | 0 |
| Other income | 2,667,000 | - | - | - |
| Total other expense, net | -17,461,000 | -23,300,000 | -20,469,000 | -21,102,750 |
| Income (loss) before income taxes | 12,130,000 | 6,486,000 | 758,000 | -30,502,500 |
| Income tax expense (benefit) | -769,000 | 1,401,000 | 726,000 | 584,500 |
| Net income (loss) | 12,899,000 | 5,085,000 | 32,000 | -31,087,000 |
| Foreign currency translation adjustment | -523,000 | 702,000 | 366,000 | -599,500 |
| Unrealized gain (loss) on available for sale investments | 17,000 | -188,000 | -155,000 | 495,500 |
| Total other comprehensive income (loss) | - | - | 211,000 | -104,000 |
| Total other comprehensive (loss) income | -506,000 | 514,000 | - | - |
| Net comprehensive income (loss) | 12,393,000 | 5,599,000 | 243,000 | -32,056,000 |
| Basic net loss per common share (in usd per share) | 0.06 | 0.02 | 0 | -0.15 |
| Diluted net loss per common share (in usd per share) | 0.06 | 0.02 | 0 | -0.15 |
| Weighted average shares outstanding, basic (in shares) | 210,176,000 | 209,519,000 | 208,882,000 | -103,317,000 |
| Weighted average shares outstanding, diluted (in shares) | 219,885,000 | 219,886,000 | 215,261,000 | -103,317,000 |
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)